We’re gearing up for the World Orphan Drug Congress Europe 2025 with the theme: “Where technology meets Human”
Volv Global sits at the crucial intersection between technology and human beings, i.e., patients and physicians, supporting favourable patient journeys and outcomes. We use each World Orphan Drug Congress as our touchpoint with the rare disease community, in particular as an opportunity to learn and share with everyone in rare disease, from patients and patient advocacy organisations, to physicians and healthcare providers, to pharma companies, to policy makers and regulators.
Meet us at the World Orphan Drug Congress Europe 2025 in Amsterdam, 27th-29th October, to find out more:
🟥 Christopher Rudolf, Founder and Chief Executive Officer, Volv Global, will be on two keynote panels:
- “Leveraging new technology for smarter decision-making in Rare Disease drug development and access.” – 09.00 on Wednesday, 29th October.
- the second panel to be announced
🟥 Christopher will also have another talk, details to come!
🟥 Our booth: #10.301
As a Gold Sponsor, Volv Global has a number of discounted tickets for our clients and partners – do contact us if you need a ticket.
Looking forward to having great discussions with you there – please Contact Us to book a meeting!
Link to WODC EU 2025: World Orphan Drug Congress 2025 | Amsterdam
